| Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen | TA515 | | |
| Cabozantinib for treating medullary thyroid cancer | TA516 | | |
| Learning disabilities and behaviour that challenges: service design and delivery | NG93 | | |
| Emergency and acute medical care in over 16s: service delivery and organisation | NG94 | | |
| Physical activity and the environment | NG90 | | |
| Brodalumab for treating moderate to severe plaque psoriasis | TA511 | | |
| Tivozanib for treating advanced renal cell carcinoma | TA512 | | |
| Obinutuzumab for untreated advanced follicular lymphoma | TA513 | | |
| Attention deficit hyperactivity disorder | QS39 | | |
| Mosaicplasty for symptomatic articular cartilage defects of the knee | IPG607 | | |
| Laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina | IPG608 | | |
| Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee | TA508 | | |
| Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer | TA509 | | |
| Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C | TA507 | | |
| People's experience in adult social care services: improving the experience of care and support for people using adult social care services | NG86 | | |
| Coban 2 for venous leg ulcers | MIB140 | | |
| Aortic valve reconstruction with processed bovine pericardium | IPG604 | | |
| Mental health of adults in contact with the criminal justice system | QS163 | | |
| Parkinson's disease | QS164 | | |
| Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women | TA160 | | |
| Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women | TA161 | | |
| Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency | HST7 | | |
| Pancreatic cancer in adults: diagnosis and management | NG85 | | |
| Atrial fibrillation | QS93 | | |
| Pirfenidone for treating idiopathic pulmonary fibrosis | TA504 | | |
| Intrabeam radiotherapy system for adjuvant treatment of early breast cancer | TA501 | | |
| Ibrutinib for treating relapsed or refractory mantle cell lymphoma | TA502 | | |
| Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer | TA503 | | |
| EpiFix for chronic wounds | MIB139 | | |
| Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones | MIB138 | | |
| Sore throat (acute): antimicrobial prescribing | NG84 | | |
| Lenvatinib with everolimus for previously treated advanced renal cell carcinoma | TA498 | | |
| Glecaprevir–pibrentasvir for treating chronic hepatitis C | TA499 | | |
| Ceritinib for untreated ALK-positive non-small-cell lung cancer | TA500 | | |
| Age-related macular degeneration | NG82 | | |
| MammaTyper in vitro diagnostic test for determining breast cancer subtypes | MIB135 | | |
| Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer | MIB137 | | |
| TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum | MIB134 | | |
| Golimumab for treating non-radiographic axial spondyloarthritis | TA497 | | |
| Next-generation sequencing panel for solid tumour cancers in children | MIB133 | | |
| Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | TA495 | | |
| Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | TA496 | | |
| Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
| Endobronchial valve insertion to reduce lung volume in emphysema | IPG600 | | |
| Transcutaneous microwave ablation for severe primary axillary hyperhidrosis | IPG601 | | |
| Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure | IPG602 | | |
| Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death | IPG603 | | |
| Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) | DG14 | | |
| Transvaginal mesh repair of anterior or posterior vaginal wall prolapse | IPG599 | | |
| Naltrexone–bupropion for managing overweight and obesity | TA494 | | |